Signaling pathways
-
BA4587 ILK-IN-3Summary: ILK-IN-3 is an orally active inhibitor. - BA4588 PLN-1474Summary: PLN-1474 is an orally active, selective inhibitor.
- BA4589 Gly-Arg-Gly-Asp-SerSummary: Gly-Arg-Gly-Asp-Ser is a pentapeptide.
- BA4590 ZaurategrastSummary: Zaurategrast (CT7758) is an effective.
- BA4591 CertepetideSummary: Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD).
- BA4592 BMS-587101Summary: BMS-587101 is a potent antagonist with oral activity.
- BA4593 RO0270608Summary: RO0270608, the active metabolite of R411, is a dual integrin antagonist.
- BA4594 EfalizumabSummary: Efalizumab is a modulator that targets T cells and is a humanized monoclonal antibody to the LFA-1α subunit.
- BA4595 EMD527040Summary: EMD527040 is a potent and highly selective antagonist with antifibrotic activity.
- BA4596 SB-267268Summary: SB-267268 is a selective and non-peptide and integrin antagonist.